ClearPoint Neuro, Inc. (CLPT)
USD 15.08
(-7.71%)
USD 15.08
(-7.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.72 Million | -16.16 Million | -12.69 Million | -7.8 Million | -2.84 Million | -4.63 Million |
| Net Income | -22.08 Million | -16.43 Million | -14.41 Million | -6.78 Million | -5.53 Million | -6.16 Million |
| Depreciation & Amortization | 1.45 Million | 777 Thousand | 692 Thousand | 553 Thousand | 250.56 Thousand | 109.43 Thousand |
| Deferred income taxes | 1.2 Million | - | 202 Thousand | -896 Thousand | - | -64.31 Thousand |
| Stock-based compensation | 6.07 Million | 4.12 Million | 2.07 Million | 1.09 Million | 799.11 Thousand | 1.23 Million |
| Change in working capital | -356 Thousand | -4.28 Million | -1.68 Million | -2.66 Million | 911.31 Thousand | -383.65 Thousand |
| Other non-cash items | -18 Thousand | -346 Thousand | 425 Thousand | 893 Thousand | 729.28 Thousand | 640.02 Thousand |
| Investing Cash Flow | 8.94 Million | -10.73 Million | -168 Thousand | -482 Thousand | -160.19 Thousand | -63.49 Thousand |
| Investments in PPE | -1.05 Million | -1.14 Million | -168 Thousand | -482 Thousand | -160.19 Thousand | -63.49 Thousand |
| Acquisitions | - | 893 Thousand | - | - | - | - |
| Investment purchases | - | -21.59 Million | - | - | - | - |
| Sales/Maturities of investments | 10 Million | 12 Million | - | - | - | - |
| Other Investing Activities | 9.66 Million | -893 Thousand | - | -441 Thousand | -150 Thousand | - |
| Financing Cash Flow | 296 Thousand | 409 Thousand | 46.87 Million | 22.69 Million | 5.6 Million | -1.49 Million |
| Debt repayment | - | - | - | -2.83 Million | -2.13 Million | -2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -210 Thousand | -336 Thousand | -599 Thousand | - | - | - |
| Common Stock Issuance | 506 Thousand | 745 Thousand | 47.47 Million | 376 Thousand | 7.42 Million | 77.5 Million |
| Other Financing Activities | 506 Thousand | 745 Thousand | 47.47 Million | 25.15 Million | 313.79 Thousand | -76.99 Million |
| Accounts receivables | -1.8 Million | -211 Thousand | 627 Thousand | -791 Thousand | 143.97 Thousand | -284.48 Thousand |
| Accounts payables | -649 Thousand | 1.59 Million | -762 Thousand | -453 Thousand | 928.16 Thousand | -316.17 Thousand |
| Inventory | 1.24 Million | -4.42 Million | -1.71 Million | -25 Thousand | -1.02 Million | 122.22 Thousand |
| Other working capital | 851 Thousand | -1.24 Million | 165 Thousand | -1.39 Million | 863.79 Thousand | 94.78 Thousand |
| Cash at beginning of period | 27.61 Million | 54.1 Million | 20.09 Million | 5.69 Million | 3.1 Million | 9.28 Million |
| Cash at end of period | 23.14 Million | 27.61 Million | 54.1 Million | 20.09 Million | 5.69 Million | 3.1 Million |
| Capital Expenditure | -1.05 Million | -1.14 Million | -168 Thousand | -482 Thousand | -160.19 Thousand | -63.49 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.47 Million | -26.49 Million | 34.01 Million | 14.4 Million | 2.59 Million | -6.18 Million |
| Free Cash Flow | -14.77 Million | -17.31 Million | -12.86 Million | -8.29 Million | -3 Million | -4.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.4 Million | -4.14 Million | -22.08 Million | -4.61 Million | -4.8 Million | -7.05 Million |
| Depreciation & Amortization | 463 Thousand | 474 Thousand | 1.45 Million | 424 Thousand | 423 Thousand | 339 Thousand |
| Deferred income taxes | - | - | 1.2 Million | -2.17 Million | 449 Thousand | 283 Thousand |
| Stock-based compensation | 1.79 Million | 1.5 Million | 6.07 Million | 1.54 Million | 1.58 Million | 1.64 Million |
| Change in working capital | -172 Thousand | -1.54 Million | -356 Thousand | 1.11 Million | 543 Thousand | -247 Thousand |
| Other non-cash items | 1.69 Million | 2.35 Million | -18 Thousand | 2.54 Million | 14 Thousand | -43 Thousand |
| Investing Cash Flow | - | - | 8.94 Million | -188 Thousand | -235 Thousand | 9.51 Million |
| Investments in PPE | - | - | -1.05 Million | -188 Thousand | -235 Thousand | -490 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 10 Million | - | - | 10 Million |
| Other Investing Activities | - | - | 9.66 Million | -167 Thousand | - | 9.83 Million |
| Financing Cash Flow | 160 Thousand | 16.05 Million | 296 Thousand | 155 Thousand | -91 Thousand | 237 Thousand |
| Debt repayment | - | - | - | -553 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 288 Thousand | -151 Thousand | -210 Thousand | -37 Thousand | -91 Thousand | -77 Thousand |
| Common Stock Issuance | 288 Thousand | 16.2 Million | 506 Thousand | 192 Thousand | - | 314 Thousand |
| Other Financing Activities | -128 Thousand | -151 Thousand | 506 Thousand | 192 Thousand | -91 Thousand | 314 Thousand |
| Accounts receivables | -602 Thousand | 846 Thousand | -1.8 Million | -1.14 Million | -74 Thousand | -404 Thousand |
| Accounts payables | 1.65 Million | -931 Thousand | -649 Thousand | 374 Thousand | -275 Thousand | 109 Thousand |
| Inventory | -373 Thousand | 53 Thousand | 1.24 Million | 983 Thousand | 169 Thousand | 672 Thousand |
| Other working capital | -854 Thousand | -1.5 Million | 851 Thousand | 898 Thousand | 723 Thousand | -624 Thousand |
| Cash at beginning of period | 35.35 Million | 23.14 Million | 27.61 Million | 24.34 Million | 26.46 Million | 21.79 Million |
| Cash at end of period | 32.84 Million | 35.35 Million | 23.14 Million | 23.14 Million | 24.34 Million | 26.46 Million |
| Capital Expenditure | - | - | -1.05 Million | -188 Thousand | -235 Thousand | -490 Thousand |
| Effect of forex changes on cash | - | - | - | -48.28 Million | -1.86 Million | 50.15 Million |
| Net cash flow / Change in cash | -2.5 Million | 12.21 Million | -4.47 Million | -1.2 Million | -2.12 Million | 4.67 Million |
| Free Cash Flow | -2.66 Million | -3.84 Million | -14.77 Million | -1.35 Million | -2.03 Million | -5.56 Million |
PLG
CYIO
SAL
GCARSOA1
URAVI
IZOZF